Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06674980 · ClinicalTrials.gov registry record · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
A NA study of Cardiovascular Diseases and Diabetes Mellitus, sponsored by C5 Biomedical.
- Recruiting
- Registry status
- NA
- Development phase
- 177
- Enrollment target
- 1
- Study location
NCT06674980: Recruiting NA study of Cardiovascular Diseases and Diabetes Mellitus, sponsored by C5 Biomedical.
NCT06674980 is a NA study of Cardiovascular Diseases and Diabetes Mellitus that is actively recruiting participants, run by C5 Biomedical. The registered enrollment target is 177 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06674980, a NA study of Cardiovascular Diseases and Diabetes Mellitus, is actively recruiting participants, sponsored by C5 Biomedical.
- RECRUITING
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.
Primary Outcome
The proportion of subjects achieving complete wound closure of target ulcer.
Conditions Studied
Interventions
- OTHER Standard of Care - DFU
- OTHER AM/Single - DFU
- OTHER AM/Double - DFU
- OTHER Standard of Care - VLU
- OTHER AM/Single - VLU
Study Locations (1)
Louisiana
- Poirot Podiatry - Metairie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2024-12-20 |
| Est. Completion | 2027-01-22 |
| Phase | NA |
What NCT06674980 shows while recruiting
NCT06674980 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 10 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 5 interventions - of which Standard of Care - DFU is the first listed.
NCT06674980 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT06674980 about?
NCT06674980 is a clinical study titled "Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs". The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.
What is the current status of trial NCT06674980?
This trial is currently recruiting. It is a NA study. The enrollment target is 177 participants. The study started on 2024-12-20. Estimated completion is 2027-01-22.
What conditions does trial NCT06674980 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Diabetes Mellitus, Vascular Diseases, Glucose Metabolism Disorders, Pathologic Processes.
What interventions are being tested in trial NCT06674980?
The interventions under investigation include: Standard of Care - DFU (OTHER), AM/Single - DFU (OTHER), AM/Double - DFU (OTHER), Standard of Care - VLU (OTHER), AM/Single - VLU (OTHER).
Who is sponsoring clinical trial NCT06674980?
This trial is sponsored by C5 Biomedical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06674980 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06674980's enrollment target sits among peer trials
177 160th of 300 higher than 141 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06719011 · 177 participants · Phase 1
A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI